GIPL · Global Innovative Platforms Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q2 '26 | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q3 '24 | Q2 '24 | Q1 '24 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $30.0K | - | - | - | $0 | $0 | $0 | $0 | $0 |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | $3.5K | $34.3K | - | - | - | - | - | - | - | - |
| SG&A | - | $68.7K | $211.8K | $151.4K | $120.5K | $6.4K | $3.9K | $49.5K | $2.6K | $68.9K |
| Total Operating Expenses | $257.9K | $79.4K | $211.8K | $151.4K | $120.5K | $6.4K | $3.9K | $49.5K | $2.6K | $68.9K |
| D&A | - | $5.0K | - | - | - | - | - | - | - | - |
| Operating Income | ($151.4K) | ($49.4K) | ($211.8K) | ($151.4K) | ($120.5K) | ($6.4K) | ($3.9K) | ($49.5K) | ($2.6K) | ($68.9K) |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | $0 | - | - | - | - | $0 | $0 | $0 | $0 | $0 |
| Net Income | ($151.4K) | ($49.4K) | ($211.8K) | ($151.4K) | ($120.5K) | ($6.4K) | ($3.9K) | ($49.5K) | ($2.6K) | ($68.9K) |
| EPS - Basic | ($0.00) | ($0.00) | ($0.01) | ($0.00) | ($0.00) | $0.00 | $0.00 | ($0.14) | ($0.01) | ($0.11) |
| EPS - Diluted | - | ($0.00) | ($0.01) | ($0.00) | ($0.00) | $0.00 | $0.00 | ($0.00) | ($0.00) | ($0.11) |
Balance Sheet
| Line item | Q2 '26 | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q3 '24 | Q2 '24 | Q1 '24 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $327.3K | $49.0K | $17.8K | $155.9K | $148.5K | $15 | $596 | $1.7K | $415 | $3.0K |
| Accounts Receivable | $0 | - | - | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | $284 | $284 | $109 | $2.0K | $14.4K | $753 | $13.1K | $11.8K | $3.0K | $6.2K |
| Current Assets | $366.6K | $54.5K | $199.3K | $166.9K | $148.5K | $15 | $596 | $1.7K | $415 | $3.0K |
| Total Assets | $592.0K | $225.0K | $199.3K | $166.9K | $148.5K | $15 | $596 | $1.7K | $415 | $3.0K |
| Current Liabilities | $2.3K | $65.8K | $11.6K | $3.2K | $14.4K | $33.2K | $201.0K | $198.2K | $364.4K | $241.7K |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $2.3K | $65.8K | $11.6K | $3.2K | $14.4K | $33.2K | $201.0K | $198.2K | $364.4K | $241.7K |
| Stockholders' Equity | $589.7K | $159.6K | $187.7K | $163.7K | $134.1K | ($33.1K) | ($200.4K) | ($196.5K) | ($364.0K) | ($238.8K) |
| Retained Earnings | ($1.46M) | ($1.30M) | ($1.26M) | ($809.0K) | ($657.7K) | ($537.2K) | ($454.4K) | ($450.5K) | ($401.0K) | ($274.3K) |
Cash Flow
| Line item | Q2 '26 | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q3 '24 | Q2 '24 | Q1 '24 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | $12.7K | - | - | ($138.1K) | - | - | ($24.6K) | - | - |
| Investing Cash Flow | - | - | - | - | - | - | - | $0 | - | - |
| Financing Cash Flow | - | $18.5K | - | - | $286.5K | - | - | $25.9K | - | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q2 '26 | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q3 '24 | Q2 '24 | Q1 '24 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | - | -164.8% | - | - | - | - | - | - | - | - |
| EBITDA margin | - | -148.1% | - | - | - | - | - | - | - | - |
| Net margin | - | -164.8% | - | - | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | 114.2% | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | 229.2% | - | - | - | - | - | - | - | - |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | -25.6% | -22.0% | -106.3% | -90.7% | -81.1% | -42400.0% | -652.2% | -2935.8% | -638.6% | -2325.9% |
| Return on equity | -25.7% | -31.0% | -112.9% | -92.5% | -89.9% | 19.2% | 1.9% | 25.2% | 0.7% | 28.8% |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 160.49 | 0.83 | 17.17 | 51.70 | 10.30 | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 |
| Quick ratio | 160.49 | 0.83 | 17.17 | 51.70 | 10.30 | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 |
| Cash ratio | 143.29 | 0.74 | 1.54 | 48.28 | 10.30 | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 1.00 | 1.41 | 1.06 | 1.02 | 1.11 | -0.00 | -0.00 | -0.01 | -0.00 | -0.01 |
| Liabilities / Assets | 0.00 | 0.29 | 0.06 | 0.02 | 0.10 | 2210.20 | 337.24 | 117.63 | 878.00 | 81.63 |
| Efficiency | ||||||||||
| Asset turnover | 0.00 | 0.13 | - | - | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | 0.0x | 31.0x | 23.7x | 46.9x | 26.7x | - | - | - | - | - |
| P / S | - | 164.8x | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | -0.0% | 59.0% | -3230.5% | -3793.8% | -143.5% | -140.0% | 94.4% | 43.2% | 59.9% | -1254.9% |
| Net income growth (YoY) | -0.0% | 59.0% | -3230.5% | -3793.8% | -143.5% | -140.0% | 94.4% | 43.2% | 59.9% | -1254.9% |
| EPS growth (YoY) | - | 66.7% | - | - | -50.0% | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 260.2% | 19.0% | - | - | - | 90.9% | 16.1% | -15.7% | -340.0% | - |
Peer comparison
Same SIC group: Surgical & Medical Instruments & Apparatus
Comparing Global Innovative Platforms Inc. against the 5 most active filers in the same SIC group.